Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 435 shares at $5.30 ($2K) on 2020-09-03, disclosed to the SEC on 2020-09-08.
Seasonal sale ($2k) by See Remarks — this insider has traded CLVS in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.30 | 198 | $1K | 45.5% |
| 2 | $5.30 | 237 | $1K | 54.5% |
| Total | $5.30 avg | 435 | $2K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |